Part 806 Reports: When to Submit?
Is It a Device Recall … or Product Enhancement?

Thursday, May 30, 2019 · 11:00 a.m. - 12:30 p.m. EDT

Devicemaker alert: The FDA is on the lookout for Part 806 violations and will deal out appropriate sanctions for violation. Can you tell the difference between a device recall and a product enhancement?

Too many devicemakers would have to answer ‘no’ … and face, at the worst, a product seizure. Make sure that doesn’t happen to you by registering now for a new FDAnews webinar on Part 806 basics.

For your guide we’ve tapped Pamela Forrest Esq., a top FDA expert from the noted Washington law firm of Covington & Burling. She’ll take you on a whirlwind tour of 21 C.F.R. 806 including the subtleties that can make the difference between a warning letter and a clean bill of health. 

Webinar Takeaways:

  • 21 C.F.R. Part 806: Nuances of the regulation, when to report a recall
  • Recall-specific terms: How recalls differ from enhancements
  • Part 806 pitfalls: Handling different classes of device recalls
  • Bad things that can happen: Enforcement actions, liability and more
  • Product seizures: They’re among the worst of bad things

Part 806 can be confusing. What once was a product enhancement now may be considered a recall … and, sometimes, neither enhancement nor recall. This is the moment to figure it all out. Join us by registering today.

Who Will Benefit

  • Quality/QSR
  • Regulatory affairs
  • Inspections/audits
  • Postmarket safety
  • Commercial operations
  • Legal counsel

Webinar plus USB Audio Recording/Transcript
Learn more

$487

add to cart

Webinar only
Learn more

$287

add to cart

24/7 Encore plus USB Audio Recording/Transcript
Learn more

$487

add to cart

24/7 Encore Presentation
Learn more

$287

add to cart

USB Audio Recording/Transcript
Learn more

$287

add to cart

 

Meet Your Presenter

Pamela Forrest Esq.

Partner in the Food, Drug, and Device Practice
Covington & Burling

Pamela Forrest Esq., a Partner in the Food, Drug, and Device Practice at Covington & Burling, has 25 years of experience advising medical device clients on FDA regulatory issues including premarket notification, premarket approval, product recalls, Medical Device Reporting (MDR), Quality System Regulation (QSR) compliance, establishment registration and device listing, labeling and promotion, import/export issues, and clinical trial requirements. She is a frequent writer and speaker on FDA device regulation and has testified before state legislative committees regarding device legal and regulatory issues. 

MII logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.

Phone (703) 538-7600 | Fax (703) 538-7676 | Toll free (888) 838-5578 | Email customerservice@fdanews.com

© 2019 FDAnews